关键词: 30-Day mortality Bloodstream infection Difficult to treat resistance Multidrug resistance Non-fermentative gram-negative bacteria Therapeutic management

Mesh : Acinetobacter baumannii Anti-Bacterial Agents / pharmacology therapeutic use Bacteremia / drug therapy epidemiology Drug Resistance, Bacterial Humans Retrospective Studies Stenotrophomonas maltophilia

来  源:   DOI:10.1186/s12879-021-06496-8   PDF(Pubmed)

Abstract:
BACKGROUND: The management of non-fermentative gram-negative bloodstream infection (NFGN-BSI) offers numerous challenges. In this study the aim is to analyse a large cohort of patients with NFGN-BSI recruited in the northern Italy to describe epidemiology, etiological and susceptibility pattern, therapeutic management and outcome.
METHODS: Multicentre retrospective cohort study of patients hospitalised at three large teaching hospitals in northern Italy in a fourth year period.
RESULTS: 355 BSI episodes were analyzed, due to P. aeruginosa (72.7%), A. baumannii (16.6%), and Stenotrophomonas maltophilia (10.7%). Overall, 21.4% of isolates were defined as DTR, highest rate among A. baumannii (64.4%). All-cause 30-day mortality rate was 17.5%. Rates of XDR or DTR A. baumannii isolation were significantly higher in non-surviving patients. Independent risk factors for 30-day mortality were: age (HR 1.03, 95%CI 1.00-1.04, p = 0.003), septic shock (HR 2.84, 95%CI 1.67-4.82, p < 0.001) and BSI due to Acinetobacter baumannii (HR 2.23, 95%CI 1.27-3.94, p = 0.005).
CONCLUSIONS: The overall prevalence of DTR was high in the NFGN BSI cohort analyzied, mainly among Acinetobacter baumannii episodes (64.4%). Acinetobacter baumannii is showed to be an independent predictor of mortality. These evidences marked the urgent need of new therapeutic options against this pathogen.
BACKGROUND: 79/2017/O/OssN. Approved: March14th, 2017.
摘要:
暂无翻译
公众号